Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Convertible Loan Note Offer

18 Jul 2006 15:48

Azure Holdings PLC18 July 2006 Azure Holdings plc (the "Company") Convertible Loan Note Offer The Company announces that it has today issued a letter to holders of ordinaryshares of 1p each in the Company ("Ordinary Shares"), on the share register ofthe Company on 17 July 2006, offering them the opportunity to participate in thesubscription of up to £1,200,000 nominal unsecured convertible loan stock 2008("Loan Stock"). The Loan Stock is being offered following discussions regarding a proposedacquisition by the Company ("Acquisition"). The proposed target for theAcquisition is ValiRX Limited ("ValiRX"), a biopharmaceutical developmentcompany. Discussions with ValiRX are progressing and the directors of theCompany hope to complete a reverse takeover under the AIM rules before 30September 2006. The principal terms of the Loan Stock are as follows: 1 Unless previously converted or repaid, the Loan Stock isrepayable 24 months from the date of the Loan Stock instrument under which it iscreated (the "Instrument") or at any time after 31 October 2006 at the Company'soption. 2 In partial consideration for the Loan Stock holderssubscribing for Loan Stock, a premium ("Premium") of £2 for each £1 nominal ofLoan Stock is payable, unless previously converted or paid, 24 months from thedate of the Instrument, or at any time after 31 October 2006 at the Company'soption. 3 Interest is payable from 1 November 2006 on the amount ofthe Loan Stock at the rate of two per cent. over the base rate of the Bank ofScotland plc from time to time. Interest is payable twice yearly. The firstinterest period will run from 1 November 2006 to 31 March 2007. 4 The conversion of Loan Stock ("Conversion") into OrdinaryShares is conditional upon approval by shareholders of resolutions to allotshares and disapply pre-emption rights; and if appropriate, the approval by avote of independent shareholders taken on a poll of any waiver granted by thePanel on Takeovers and Mergers of any obligation under rule 9 of the City Codeon Takeovers and Mergers which may arise from such Conversion (together the "Conversion Event") 5 Immediately prior to the Conversion Event, the Loan Stockis deemed repayable and the Premium is deemed payable. 6 On the Conversion Event, the Loan Stock and the Premiumwhich has not been repaid or paid as the case may be, will be converted intoOrdinary Shares in the capital of the Company at the rate of 100 Ordinary Sharesof the Company for each £1 otherwise due for repayment or payment. 7 So far as it is lawfully able to do so, the Company willnotify the Loan Stock holders at least 10 days in advance of the likelyoccurrence of the Conversion Event. 8 The Loan Stock is transferable in multiples of £10,000. 9 The Company is obliged to repay the Loan Stock and pay thePremium on the occurrence of certain events, including certain insolvencyevents. 10 Decisions relating to the Loan Stock are to be taken by a writtenresolution of the holders of at least two thirds in nominal value of theoutstanding Loan Stock. Applications for the Loan Stock may only be made for a minimum of £1,000 nominaland in multiples of £1,000. Applications for the Loan Stock are to be receivedby the Company at One Great Cumberland Place, London W1H 7AL by 3.00pm on 31July 2006. A copy of the letter despatched to shareholders and the Instrument are availablefor inspection, on request, at Halliwells LLP, 1 Threadneedle Street, LondonEC2R 8AW during normal business hours on any weekdays, Saturdays, Sundays andpublic holidays excluded, for one month from today. For further information, please contact: Barry Gold, Azure Holdings plcTel: 07768 948 928 David Youngman, WH Ireland Limited Tel: 0161 832 2174 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Apr 20208:00 amRNSHolding(s) in Company
30th Apr 20207:00 amRNSChange of Management Team
29th Apr 20205:42 pmRNSStatement re social media reports
24th Apr 20207:00 amRNSHolding(s) in Company
23rd Apr 202011:04 amRNSHolding(s) in Company
16th Apr 20202:05 pmRNSSecond Price Monitoring Extn
16th Apr 20202:00 pmRNSPrice Monitoring Extension
14th Apr 202012:41 pmRNSResult of General Meeting & Directorate Change
14th Apr 202010:08 amRNSChange of Director
9th Apr 20202:39 pmRNSChange of Arrangements for General Meeting
1st Apr 202011:59 amRNSResult of General Meeting
1st Apr 20207:00 amRNSConditional Placing
30th Mar 20207:00 amRNSUpdate
25th Mar 20209:44 amRNSGeneral Meeting - Adjournment
16th Mar 20207:00 amRNSPosting of Circular & Notice of General Meeting
10th Mar 20207:00 amRNSPosting of Circular & Notice of General Meeting
4th Mar 20203:28 pmRNSShareholder Requisition Notice
17th Feb 20202:05 pmRNSSecond Price Monitoring Extn
17th Feb 20202:00 pmRNSPrice Monitoring Extension
17th Feb 202012:07 pmRNSResult of General Meeting & working capital update
12th Feb 20207:00 amRNSChange of Venue for General Meeting-17 Feb 2020
30th Jan 20202:00 pmRNSPosting of Circular & Notice of General Meeting
14th Jan 20207:00 amRNSUpdate - ValiSeek
6th Jan 20207:00 amRNSPlacing, Issue of Warrant & Appointment of Broker
16th Dec 20199:05 amRNSSecond Price Monitoring Extn
16th Dec 20199:00 amRNSPrice Monitoring Extension
16th Dec 20197:00 amRNSVAL201 Update
28th Nov 20197:00 amRNSUS Patent Grant re VAL201 & Metastatic Cancer
13th Nov 201911:33 amRNSHolding(s) in Company
13th Nov 20197:00 amRNSAppointment of Joint Broker
11th Nov 20193:30 pmRNSHolding(s) in Company
21st Oct 201911:47 amRNSPassing of Non-Executive Chairman
14th Oct 20191:23 pmRNSPlacing & Issue of Equity
9th Oct 20194:35 pmRNSPrice Monitoring Extension
26th Sep 20197:00 amRNSHalf-year Report
24th Sep 20197:00 amRNSCompany Update
10th Sep 20195:15 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSVAL201 Update
6th Aug 20197:00 amRNSCompany Update & Change of Adviser
1st Aug 20197:00 amRNSNew European patent allowance for VAL301
23rd Jul 20194:02 pmRNSHolding(s) in Company
23rd Jul 20197:00 amRNSAppointment of Joint Broker
10th Jul 20197:00 amRNSMarketing and Communications Update
9th Jul 201911:14 amRNSChange of Registered Address
4th Jul 20197:00 amRNSUpdate re VAL301
28th Jun 20191:33 pmRNSHolding(s) in Company
28th Jun 201912:31 pmRNSIssue of Equity
28th Jun 201912:03 pmRNSResult of AGM
26th Jun 201912:00 pmRNSHolding(s) in Company
26th Jun 20197:00 amRNSUS Notice of Allowance-VAL201 & Metastatic Cancer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.